Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generics
Pharma
FDA approves first radioligand equivalent
Bexlutry got its approval through the FDA’s 505(b)(2) pathway, a hybrid new drug application process that allows for reliance on reference data.
Angus Liu
Sep 15, 2026 8:38am
SK settles with MSN over generic of seizure med Xcopri: reports
Aug 19, 2026 11:21am
Drugmaker caught faking doctors’ petition to evade China price cut
Jul 8, 2026 11:31am
Aurobindo must divest 4 drugs to complete Lannett buyout: FTC
Jun 18, 2026 3:45pm
In a big win for generics drugmakers, SCOTUS sides with Hikma
Jun 4, 2026 3:11pm
Pfizer inks settlements with 2 generic Vyndamax contenders
Apr 27, 2026 11:23am
